by Mirriam Chabala on 25 Apr 2019by Mirriam Chabala on 25 Apr 2019by Sipilisiwe Ncube on 25 Apr 2019by Sandra Mulenga on 25 Apr 2019
- Goal Diggers
by Abraham Kalito on 27 Mar 2019by Abraham Kalito on 26 Mar 2019by Abraham Kalito on 26 Mar 2019by Abraham Kalito on 26 Mar 2019
by Stuart Lisulo on 25 Apr 2019by Stuart Lisulo on 24 Apr 2019by Mirriam Chabala on 24 Apr 2019by Stuart Lisulo on 23 Apr 2019
by Joseph Mwenda on 25 Apr 2019by Daniel Chansa on 25 Apr 2019by Zondiwe Mbewe on 25 Apr 2019by Zondiwe Mbewe on 25 Apr 2019
- Editor's Choice
by Diggers Reporter on 4 Mar 2019by Andyford Mayele Banda on 29 Jan 2019by Davies Mwila on 22 Jan 2019by Diggers Reporter on 17 Jan 2019
by Diggers Editor on 25 Apr 2019by Diggers Editor on 24 Apr 2019by Diggers Editor on 22 Apr 2019by Diggers Editor on 19 Apr 2019
by Diggers Correspondent on 23 Apr 2019by Felix Kashweka on 2 Apr 2019by Thomas Mulenga on 29 Mar 2019by McQueen Zaza on 26 Mar 2019
- Guest Diggers
by Dr Munyonzwe Hamalengwa on 18 Apr 2019by Chisoni Mumba, PhD on 14 Apr 2019by Dr Chisoni Mumba, PhD on 28 Mar 2019by Sishuwa Sishuwa on 25 Mar 2019
Govt in panic after supplying toxic Chinese drug to hospitalsBy Mirriam Chabala on 6 Mar 2019
The Ministry of Health is in panic mode, making frantic efforts to withdraw a Chinese manufactured drug which has turned out to be toxic on patients in various hospitals across the country.
Minister Dr Chitalu Chilufya confirmed the case to News Diggers but said a full statement would be issued once the technocrats carry out a thorough investigation on the supply.
His Permanent Secretary Dr Kennedy Malama has issued a circular, advising all health facilities, provincial medical administrations and district health directors to quarantine a drug called “Gentamycin Sulphate BP injection” manufactured by CSPC Ouyi Pharmaceutical Company Limited in China, after receiving reports of its devastating side effects on patients from the Zambia Medicines Regulatory Authority (ZAMRA).
ZAMRA reported that the Gentamed injection batch no. S MD180107 and 180108 led to severe headaches and vomiting in patients who were administered the drug from various health facilities across the country.
“Zambia Medicines Regulatory Authority has received reports of adverse reactions [such as] severe headache and vomiting from various health facilities across the country following the administration of the above stated product. In this regard, the ministry directs all institutions to quarantine the stated batches with immediate effect, in order to allow the Authority to carry out further investigations. Institutions will be guided on the next steps after the investigations are concluded,” stated Dr Malama in his letter dated March 1, 2019.
Dr Chilufya declined to take further questions from this reporter, apart from confirming that the ministry was aware of the situation and a statement would be issued.
“A statement will be issued on that subject. I am not saying anything else, a statement will be issued. But for now I would rather technocrats do there work then a statement will be issued,” said Dr Chilufya before hanging up the phone conversation.
Meanwhile, Pharmaceutical Society of Zambia president Jerome Kanyika accused the supplier of delivering drugs which did not match with the samples presented when bidding for the supply tender.
“What happens when someone is bringing their samples to be registered in this country, they bring the best of their samples. But in the long run as they win tenders or contracts, you find that they change in the way they do things. Like where someone says ‘in this tablet, there is this amount of drugs’, but then as they win the tenders, they bring a tablet that does not consist the amount of drugs that they talked about when registering. So what happens once those people bring their products in the country and they are allowed to be in the Health institutions, the Zambia Medicines Regulatory Authority is mandated now to do what is called Pharmacovigilance checking. Meaning they are checking how the medicines are working, and if those medicines are giving people any side effects or not,” Kanyika explained.
Further, Kanyika hailed ZAMRA and the Ministry of Health for taking quick action after identifying the problem with the affected drug.
“So in that process that’s when ZAMRA now tells what exactly the drugs contain and that problems truly lies with the supplier of a particular drug. So in this case, the one who is liable to whatever may happen is the supplier of that medicine. And we need to appreciate ZAMRA for being proactive in this matter and notifying everyone. As I am speaking to you right now, all our members in these government institutions have already quarantined that medicine, they are not using it on people. They are using alternative drugs because this particular one is still under investigations,” said Kanyika.
“ZAMRA should continue to be proactive the way they have shown to be proactive in this matter. And to the suppliers, let’s make sure that they supply the drugs that they bring for testing unlike them trying to alter what they bring in when registering the medicines. As for pharmacists who are accessing this medicine, please let’s quarantine everything so that we protect the general public, as our basic role is to protect the general public and every person that comes in the public health institutions. So it’s kudos to ZAMRA and the Permanent Secretary for being proactive in notifying the general public within a short period of time. We need to appreciate ourselves for that good work that has been done.”
In December 2019, the Zambia Pharmaceuticals Business Forum (ZPBF) raised a red flag against the Ministry of Health for exclusively awarding tenders for the supply of drugs to companies of personal interests, against the public procurement guidelines.
ZPBF wrote to Ministry of Health Permanent Secretary, demanding the cancellation of tender number MoH/SP/016/17, among others, which was not subjected to open and inclusive bidding.
ZPBF listed some of the questionable tenders as: “Tender for the supply of essential medicines, tender No MoH/SP/O16/17 with an estimated value of more than US$80 million. Tender for the supply of cancer drugs, tender No MoH/SP/009/17 with an estimated value of more than US$40 million and the award of a 2-year framework for Orthopedic Implants.”
Full story: https://diggers.news/local/2017/12/27/zpbf-exposes-drug-scandal-at-ministry-of-health/
About Mirriam Chabala
Mirriam Chabala is a Zambian journalist who covers current affairs and writes in-depth feature articles on social issues.
Email: mirriam [at] diggers [dot] news
- NDC will work with UPND in 2021 if Zambians want us to – Kambwili - 25 Apr 2019
- HRC urges govt to enact law criminalizing torture - 25 Apr 2019
- Forcing MPs to attend Dialogue Forum unconstitutional – Mweetwa - 24 Apr 2019
- Bloomberg data proves Mwanakatwe wrong - 24 Apr 2019
- Police record 212 Easter accidents - 24 Apr 2019
- Nkomeshya's Soli Establishment obtains injunction to halt ZAF, Kingsland City project
- Debt servicing has left govt little money to meet obligations – BoZ
- ZAF officer in court for torturing 11-year-old niece
- NDC will work with UPND in 2021 if Zambians want us to - Kambwili
- UPND still strong in Kasama, despite GBM departure - Mulenga
Subscribe for email alerts
ArchivesMay0 PostsJun0 PostsJul0 PostsAug0 PostsSep0 PostsOct0 PostsNov0 PostsDec0 Posts
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
The News Diggers
Deputy News Editor
Plot No. Lus/9812/649-MC8
off Alex Chola Road
P.O. Box 32147
Telephone or WhatsApp:
diggers [at] diggers [dot] news
editor [at] diggers [dot] news
Send this to a friend